Catalyst Pharmaceuticals Cash Flow Statement (2010-2026) | CPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	12.18M	10.33M	9.31M	13.24M	21.62M	22.75M	34.25M	29.57M	37.76M	-30.76M	17.04M	23.27M	40.79M	43.88M	46.48M	56.74M	52.11M	52.78M	45.93M	63.73M
Depreciation and Depletion (Quarter)	0.03M	0.03M	0.03M	0.03M	0.04M	0.04M	0.04M	0.07M	0.08M	0.08M	0.08M	0.09M	0.09M	0.11M	0.11M	0.12M	0.12M	0.07M	0.07M	0.07M
Share-based Compensation (Quarter)	1.52M	1.51M	1.47M	1.90M	2.02M	2.06M	1.93M	2.89M	3.30M	3.81M	4.25M	8.25M	4.41M	4.42M	5.17M	5.85M	7.60M	5.67M	5.66M	6.26M
Deferred Taxes (Quarter)	-2.72M	-2.30M	-2.75M	-1.90M	-0.82M	-0.93M	-1.28M	1.52M	3.24M	13.94M	-0.88M	1.75M	1.61M	8.58M	-2.56M	2.32M	2.43M	-2.42M	4.51M	2.34M
Gains from Sales and Divestitures (Quarter)															0.36M				0.33M
Gains from Investment Securities (Quarter)	0.09M		0.14M		0.63M	0.13M	31.12M	0.48M		1.09M	21.74M	0.04M	0.04M	0.04M	0.46M	0.51M	12.18M	11.33M	0.91M	12.43M
Non-cash Items (Quarter)															7.35M				7.13M
Cash from Operations (Quarter)	15.68M	21.71M	19.18M	8.48M	26.19M	41.30M	40.08M	12.07M	30.75M	45.13M	55.65M	31.93M	64.14M	72.87M	70.88M	60.04M	71.30M	32.44M	44.89M	59.59M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)						0.50M	-0.54M		7.90M	7.90M	-0.17M	-0.15M	7.90M	7.90M	36.58M	0.06M	0.80M	0.50M	37.26M	9.70M
Depreciation & Amortization (CF) (Quarter)	0.03M	0.03M	0.03M	0.03M	0.04M	0.04M	0.04M	0.07M	0.08M	0.08M	0.08M	0.09M	0.09M	0.11M	0.11M	0.12M	0.12M	0.07M	0.07M	0.07M
Change in Working Capital
Change in Receivables (Quarter)	0.69M	0.33M	-0.01M	3.93M	-0.96M	-0.25M	1.10M	22.96M	9.39M	5.25M	5.46M	6.98M	-3.32M	1.09M	7.21M	5.79M	-5.40M	40.55M	20.07M	4.36M
Change in Inventory (Quarter)	2.71M	-0.15M	0.92M	-0.04M	0.02M	-0.72M	-0.33M	-0.58M	0.42M	-1.72M	6.61M	4.31M	-1.94M	2.00M	-0.48M	0.24M	-0.46M	9.09M	9.22M	-2.24M
Change in Account Payables (Quarter)	0.36M	-0.17M	0.02M	2.37M	-2.82M	0.21M	1.45M	-0.58M	1.03M	0.18M	10.20M	-4.53M	-3.15M	4.45M	5.03M	-5.40M	-5.67M	3.57M	2.11M	-4.05M
Change in Accured Expenses (Quarter)	1.55M	4.57M	6.44M	-6.50M	2.37M	9.02M	11.51M	-2.42M	-5.13M	5.16M	8.19M	8.47M	16.43M	20.05M	8.90M	-2.55M	8.27M	13.24M	5.21M	-9.21M
Other Working Capital Changes (Quarter)		-4.84M	-0.08M	0.56M	-0.58M	-0.21M	1.04M	0.19M	1.70M	5.33M	-7.56M	-0.09M	11.10M	-5.17M	-6.22M	-0.10M	0.48M	-0.69M	0.48M	-0.11M
Investing Activities
Capital Expenditures (Quarter)	0.00M	0.07M	0.04M					0.07M		0.06M	0.09M	0.20M	0.01M	0.26M	0.09M		0.03M		0.03M	0.03M
Change in Acquisitions & Divestments (Quarter)						9.87M
Cash from Investing Activities (Quarter)	-4.00M	-0.07M	-0.04M			-0.13M		-162.37M		-92.82M	-38.32M	-0.20M	-0.01M	-0.26M	-0.09M		-0.03M		-0.03M	-0.03M
Financing Activities
Other financing activities (Quarter)												0.30M
Cash from Financing Activities (Quarter)	-3.71M	-2.10M	-2.53M	-1.55M	-2.99M	3.98M	2.25M	0.15M	-0.21M	-10.13M	-0.67M	141.05M	1.16M	-5.97M	4.43M	3.06M	0.87M	4.65M	-25.58M	-12.87M
Additional items
Change in Cash (Quarter)	7.97M	19.54M	16.61M	6.93M	32.54M	45.15M	42.33M	-150.15M	30.54M	-57.82M	16.66M	172.78M	65.28M	66.64M	75.22M	63.10M	72.14M	37.09M	19.28M	46.69M
Free Cash Flow (Quarter)	15.67M	21.64M	19.14M	8.48M	26.19M	41.30M	40.08M	12.00M	30.75M	45.06M	55.55M	31.73M	64.12M	72.61M	70.79M	60.04M	71.27M	32.44M	44.86M	59.56M
Net Cash Flow (Quarter)	7.97M	19.54M	16.61M	6.93M	23.20M	45.15M	42.33M	-150.15M	30.54M	-57.82M	16.66M	172.78M	65.28M	66.64M	75.22M	63.10M	72.14M	37.09M	19.28M	46.69M

Research Tools

Catalyst Pharmaceuticals Cash Flow Statement (2010-2026) | CPRX

Create an account

Sign In

Reset Password